Pendulum

Pendulum Therapeutics is at the forefront of biotechnology, pioneering innovative probiotic formulations that target the human microbiome to enhance health outcomes. Founded by a team of PhD scientists from renowned institutions, Pendulum is committed to improving the lives of millions by providing evidence-based solutions. The company's flagship product, Pendulum Glucose Control, is the only medical probiotic clinically shown to improve A1C levels in individuals with type 2 diabetes.

Pendulum’s mission embodies the belief that a healthy microbiome is crucial for overall wellness. By utilizing cutting-edge research and proprietary strains, including live Akkermansia, Pendulum focuses on the intricate relationship between gut health and metabolic function. Their products are formulated with the highest standards in mind, ensuring both safety and efficacy for consumers. With a dedicated team of experts in microbiology, biotechnology, and medicine, Pendulum continues to drive microbiome research forward, striving to develop interventions that can restore the balance of beneficial gut bacteria.